Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOPHTHALMICGeneric

NEO-DELTA-CORTEF

NEOMYCIN SULFATE; PREDNISOLONE ACETATE

Standard Dose
EQ 3.5MG BASE/ML;0.25%
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview NEO-DELTA-CORTEF is listed in Drugs@FDA under application 061037 (ANDA).

Marketing status: Discontinued Active ingredient NEOMYCIN SULFATE; PREDNISOLONE ACETATE Form and strength SUSPENSION/DROPS;OPHTHALMIC - EQ 3.5MG BASE/ML;0.25% Sponsor PHARMACIA AND UPJOHN Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview NEO-DELTA-CORTEF is listed in Drugs@FDA under application 061037 (ANDA). Marketing status: Discontinued Active ingredient NEOMYCIN SULFATE; PREDNISOLONE ACETATE Form and strength SUSPENSION/DROPS;OPHTHALMIC - EQ 3.5MG BASE/ML;0.25% Sponsor PHARMACIA AND UPJOHN Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
NEO-DELTA-CORTEF (NEOMYCIN SULFATE; PREDNISOLONE ACETATE) | Drug Monograph | MedicHelpline